Department of Dermatology and Allergology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Department of Dermatology, Skin Cancer Unit, Helsinki University Central Hospital, Helsinki, Finland.
Arch Dermatol Res. 2021 Dec;313(10):879-884. doi: 10.1007/s00403-020-02114-w. Epub 2020 Aug 9.
The incidence of keratinocyte carcinomas is increasing worldwide and currently there is no standardised strategy for the follow-up of patients with multiple tumours. The objective of this study was to assess the prevalence of premalignant lesions, i.e., actinic keratosis and Bowen's disease, as well as basal cell carcinoma (BCC) and cutaneous melanoma (CM) among patients with cutaneous squamous cell carcinoma (cSCC). Pathology database search was performed to identify all cSCC patients diagnosed in the Pirkanmaa region of Finland in 2006-2015. Details of the patients and tumours were obtained through medical record review. The cohort consisted of 774 patients with 1131 cSCC tumours. Overall 559 patients (72%) had premalignant lesions. A total of 316 patients (41%) had BCC and 52% of these (n = 164) had more than one BCC tumour. 50 patients (6%) had CM. Overall 180 cSCC patients (23%) had no premalignant changes, BCC or CM. The median age of these patients was 6 years less than that of the patients with premalignant lesions (p < 0.001) or BCC (p < 0.001). The invasion depth of the tumours was deeper in the patients with only cSCC (median 3 mm, interquartile range 2-6) than in those with premalignant lesions or BCC (median 2 mm, interquartile range 1-3), p < 0.001. CSCC patients have a high risk of developing multiple skin cancers and need long-term follow-up.
全球范围内,角化细胞癌的发病率正在上升,目前针对多发性肿瘤患者的随访尚缺乏标准化策略。本研究旨在评估患有皮肤鳞状细胞癌(cSCC)患者中癌前病变(即光化性角化病和 Bowen 病)、基底细胞癌(BCC)和皮肤黑色素瘤(CM)的发生率。通过对芬兰皮尔卡区 2006 年至 2015 年间诊断的所有 cSCC 患者进行病理数据库检索,以识别这些患者。通过病历回顾获取患者和肿瘤的详细信息。该队列包括 774 名患有 1131 个 cSCC 肿瘤的患者。总体而言,559 名患者(72%)存在癌前病变。共有 316 名患者(41%)患有 BCC,其中 52%(n=164)患有多个 BCC 肿瘤。50 名患者(6%)患有 CM。总体而言,180 名 cSCC 患者(23%)没有癌前病变、BCC 或 CM。这些患者的中位年龄比存在癌前病变或 BCC 的患者小 6 岁(p<0.001)。仅患有 cSCC 的患者肿瘤浸润深度更深(中位数 3mm,四分位距 2-6),比存在癌前病变或 BCC 的患者(中位数 2mm,四分位距 1-3)更深,p<0.001。仅患有 cSCC 的患者发生多种皮肤癌的风险较高,需要长期随访。